Wave Life Sciences (WVE)Director sold ~$9.9K
Aik Na Tan, Director at Wave Life Sciences, sold ~$9.9K of Wave Life Sciences shares.
- ~$9.9K
- Approx. value · 1,127 sh @ $8.75
- 15K
- Holds after · shares reported
- Traded
- Aug 5, 2025
- Filed
- Aug 8, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 13, 2025InsiderDirector sold ~$209K of WVE shares in the open market
- Aug 5, 2025 · this disclosureInsiderDirector sold ~$9.9K of WVE shares in the open market
What came next
- Aug 5, 2025InsiderDirector sold ~$43K of WVE shares in the open market
- Aug 13, 2025InsiderDirector sold ~$85K of WVE shares in the open market
- Aug 15, 2025InsiderDirector sold ~$194K of WVE shares in the open market
- Aug 22, 2025Insider · 2 peopleInsiders: 2 sales (~$2.3M)
- Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Wave Life Sciences
OQRO holds no insider, Congress, fund or contract record for Wave Life Sciences dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WVE page.
Other recent filings by Aik Na Tan, Director
The full history of Aik Na Tan, Director is on the profile page.
How this filing works
Other disclosures at Wave Life Sciences
- SEC Form 4Aug 27, 2025
- SEC Form 4Aug 27, 2025
- SEC Form 4Aug 20, 2025
- SEC Form 4Aug 14, 2025
- SEC Form 4Aug 8, 2025
- SEC Form 4Jun 14, 2025
Everything OQRO holds on this company is on its WVE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data